Hämangioendotheliom, eine bildgebende Herausforderung

Zusammenfassung

Wir berichten über einen asymptomatischen Patienten mit multiplen umschriebenen Leberveränderungen, vereinbar mit Lebermetastasen. Bioptisch-histologisch wurde die Diagnose eines Hämangioendothelioms gestellt. Das Hämangioendotheliom ist ein seltener Lebertumor, der durch die kontrastverstärkte Sonografie richtig diagnostiziert werden kann, da der Befund einer portalvenösen Minderanreicherung für leberfremdes (entzündlich oder neoplastisch) Gewebe spricht, das histologisch abgeklärt werden muss.

Abstract

We report on an asymptomatic patient with focal liver lesions. Metastases were suspected. Biopsy and histological examination revealed hemangioendothelioma. Hemangioendothelioma is a rare liver neoplasia which can be diagnosed using contrast enhanced ultrasound since portal venous hypoenhancement is indicative for neoplastic or inflammatory infiltration and, therefore, for biopsy and histological examination.

Schlüsselwörter

Leber - Ultraschall - Leitlinien - Hämangiom - Sarkom

Key words

Liver - ultrasound - guidelines - hemangioma - sarcoma

• Literatur

• 1 Cui XW, Friedrich-Rust M, De Molo C et al. Liver elastography, comments on EFSUMB elastography guidelines 2013. World J Gastroenterol 2013; 19 (38) 6329-6347
• 2 Cosgrove D, Piscaglia F, Bamber J et al. EFSUMB guidelines and recommendations on the clinical use of ultrasound elastography. Part 2: Clinical applications. Ultraschall in Med 2013; 34 (03) 238-253
• 3 Bamber J, Cosgrove D, Dietrich CF et al. EFSUMB guidelines and recommendations on the clinical use of ultrasound elastography. Part 1: Basic principles and technology. Ultraschall in Med 2013; 34 (02) 169-184
• 4 Claudon M, Dietrich CF, Choi BI et al. Guidelines and good clinical practice recommendations for Contrast Enhanced Ultrasound (CEUS) in the liver – update 2012: A WFUMB-EFSUMB initiative in cooperation with representatives of AFSUMB, AIUM, ASUM, FLAUS and ICUS. Ultrasound Med Biol 2013; 39 (02) 187-210
• 5 Claudon M, Dietrich CF, Choi BI et al. Guidelines and good clinical practice recommendations for contrast enhanced ultrasound (CEUS) in the liver – update 2012: a WFUMB-EFSUMB initiative in cooperation with representatives of AFSUMB, AIUM, ASUM, FLAUS and ICUS. Ultraschall in Med 2013; 34 (01) 11-29
• 6 Dietrich CF, Cui XW, Boozari B et al. Contrast-enhanced ultrasound (CEUS) in the diagnostic algorithm of hepatocellular and cholangiocellular carcinoma, comments on the AASLD guidelines. Ultraschall in Med 2012; 33 (Suppl. 01) S57-S66
• 7 Dietrich CF. Liver tumor characterization – comments and illustrations regarding guidelines. Ultraschall in Med 2012; 33 (Suppl. 01) S22-S30
• 8 Dietrich CF, Cui XW, Schreiber-Dietrich DG et al. EFSUMB guidelines 2011: comments and illustrations. Ultraschall in Med 2012; 33 (Suppl. 01) S11-S21
• 9 Barreiros AP, Piscaglia F, Dietrich CF. Contrast enhanced ultrasound for the diagnosis of hepatocellular carcinoma (HCC): comments on AASLD guidelines. J Hepatol 2012; 57 (04) 930-932
• 10 Dehner LP, Ishak KG. Vascular tumors of the liver in infants and children. A study of 30 cases and review of the literature. Arch Pathol 1971; 92 (02) 101-111
• 11 Tsuji M, Ozaki T, Tsutsumi A. Epithelioid hemangioendothelioma with osteoclast-like giant cells. Pathol Res Pract 2002; 198 (07) 501-505
• 12 Dietrich CF, Mertens JC, Braden B et al. Contrast-enhanced ultrasound of histologically proven liver hemangiomas. Hepatology 2007; 45 (05) 1139-1145
• 13 Wang L, Lv K, Chang XY et al. Contrast-enhanced ultrasound study of primary hepatic angiosarcoma: a pitfall of non-enhancement. Eur J Radiol 2012; 81 (09) 2054-2059
• 14 Mistry AM, Gorden DL, Busler JF et al. Diagnostic and therapeutic challenges in hepatic epithelioid hemangioendothelioma. J Gastrointest Cancer 2012; 43 (04) 521-525
• 15 Gupta R, Mathur SR, Gupta SD et al. Hepatic epithelioid hemangioendothelioma: A diagnostic pitfall in aspiration cytology. Cytojournal 2010; 6: 25
• 16 McNab PM, Quigley BC, Glass LF et al. Composite hemangioendothelioma and its classification as a low-grade malignancy. Am J Dermatopathol 2013; 35 (04) 517-522
• 17 Posligua L, Anatelli F, Dehner LP et al. Primary peritoneal epithelioid hemangioendothelioma. Int J Surg Pathol 2006; 14 (03) 257-267
• 18 Biecker E, Fischer HP, Strunk H et al. Benign hepatic tumours. Z Gastroenterol 2003; 41 (02) 191-200
• 19 Dietrich CF, Jenssen C. Focal liver lesion, incidental finding. Dtsch Med Wochenschr 2012; 137 (41) 2099-2116
• 20 Dietrich CF, Sharma M, Gibson RN et al. Fortuitously discovered liver lesions. World J Gastroenterol 2013; 19 (21) 3173-3188
• 21 Dietrich CF, Ignee A, Trojan J et al. Improved characterisation of histologically proven liver tumours by contrast enhanced ultrasonography during the portal venous and specific late phase of SHU 508A. Gut 2004; 53 (03) 401-405
• 22 Dietrich CF, Schuessler G, Trojan J et al. Differentiation of focal nodular hyperplasia and hepatocellular adenoma by contrast-enhanced ultrasound. Br J Radiol 2005; 78 (932) 704-707
• 23 Ignee A, Piscaglia F, Ott M et al. A benign tumour of the liver mimicking malignant liver disease – cholangiocellular adenoma. Scand J Gastroenterol 2009; 44 (05) 633-636
• 24 Schuessler G, Fellbaum C, Fauth F et al. The infammatory pseudotumour – an unusual liver tumour. Ultraschall in Med 2006; 27 (03) 273-279
• 25 Dietrich CF, Ignee A, Greis C et al. Artefakte und Fallgruben der Kontrastmittelsonografie der Leber. Ultraschall in Med 2013; 34: 2-22
• 26 Dietrich CF, Ignee A, Hocke M et al. Pitfalls and Artefacts using Contrast Enhanced Ultrasound. Z Gastroenterol 2011; 49 (03) 350-356
• 27 Mork H, Ignee A, Schuessler G et al. Analysis of neuroendocrine tumour metastases in the liver using contrast enhanced ultrasonography. Scand J Gastroenterol 2007; 42 (05) 652-662
• 28 Ignee A, Weiper D, Schuessler G et al. Sonographic characterisation of hepatocellular carcinoma at time of diagnosis. Z Gastroenterol 2005; 43 (03) 289-294
• 29 Piscaglia F, Cucchetti A, Dietrich CF et al. Towards new tools for refined management of patients with advanced hepatocellular carcinoma under systemic therapy: some enthusiasm with a word of caution. J Hepatol 2013; 59 (05) 924-925